Treatment options for prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Stromal Cells Neoplastic Cells, Circulating

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases36

Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Disease Progression Neoplasm Metastasis Adenocarcinoma Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Neoplasm Recurrence, Local Lung Neoplasms Carcinoma Prostatic Neoplasms, Castration-Resistant Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Pancreatic Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Disease Models, Animal Prostatitis Urinary Bladder Neoplasms Colorectal Neoplasms Neovascularization, Pathologic Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Erectile Dysfunction Carcinoma, Squamous Cell Liver Neoplasms Recurrence Rectal Neoplasms Neoplastic Cells, Circulating Radiation Injuries

Chemicals and Drugs68

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Antineoplastic Agents Tosyl Compounds Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride Metribolone Taxoids RNA, Small Interfering Cancer Vaccines Flutamide Anticarcinogenic Agents Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors PTEN Phosphohydrolase DNA, Neoplasm Antineoplastic Agents, Phytogenic Antigens, Neoplasm Testosterone Congeners Nitriles Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Proto-Oncogene Proteins c-akt Azasteroids Phenylthiohydantoin Antibodies, Monoclonal Receptor, erbB-2 Racemases and Epimerases Tumor Suppressor Protein p53 RNA, Neoplasm MicroRNAs Transcription Factors Cholestenone 5 alpha-Reductase Estramustine Leuprolide Tumor Suppressor Proteins Receptors, Estrogen Goserelin Glutathione S-Transferase pi Paclitaxel Enzyme Inhibitors DNA-Binding Proteins Proto-Oncogene Proteins Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Prostatic Secretory Proteins Proto-Oncogene Proteins c-bcl-2 Androgen-Binding Protein Kallikreins Steroid 17-alpha-Hydroxylase DNA Primers Diphosphonates Oncogene Proteins, Fusion Fluorouracil Insulin-Like Growth Factor Binding Protein 3 Cisplatin Plant Extracts Antibodies, Monoclonal, Humanized Carotenoids

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Prostatectomy Orchiectomy Early Detection of Cancer Treatment Outcome Neoplasm Staging Neoplasm Grading Prognosis Risk Factors Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Follow-Up Studies Digital Rectal Examination Neoplasm Transplantation Prospective Studies Transplantation, Heterologous Risk Assessment Immunohistochemistry Survival Rate Survival Analysis Blotting, Western Gene Expression Profiling Combined Modality Therapy Case-Control Studies Risk Biopsy Transurethral Resection of Prostate Sensitivity and Specificity Brachytherapy Incidence Disease-Free Survival Biopsy, Needle Antineoplastic Combined Chemotherapy Protocols Cohort Studies Clinical Trials as Topic Tumor Burden Odds Ratio Radiotherapy Transfection Molecular Targeted Therapy Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Predictive Value of Tests Multivariate Analysis Questionnaires Registries Tissue Array Analysis Castration SEER Program Nomograms Logistic Models Radiotherapy Dosage Polymerase Chain Reaction Reproducibility of Results Disease Models, Animal Drug Screening Assays, Antitumor Radiotherapy, Conformal Models, Biological Mass Screening Confidence Intervals Immunotherapy Chemotherapy, Adjuvant Flow Cytometry Gene Knockdown Techniques Immunoenzyme Techniques Tomography, X-Ray Computed Drug Administration Schedule Radiotherapy, Intensity-Modulated Genetic Therapy Palliative Care Radiotherapy Planning, Computer-Assisted Treatment Failure In Situ Hybridization, Fluorescence Proportional Hazards Models Patient Selection Feasibility Studies Drug Delivery Systems Clinical Trials, Phase III as Topic Real-Time Polymerase Chain Reaction Magnetic Resonance Imaging ROC Curve Randomized Controlled Trials as Topic Pilot Projects

Psychiatry and Psychology3

Decision Making Erectile Dysfunction Smoking

Phenomena and Processes42

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Signal Transduction Time Factors Cell Growth Processes Sensitivity and Specificity Down-Regulation Cell Survival Genotype Cell Division Odds Ratio Cell Movement Transfection Dose-Response Relationship, Drug DNA Methylation Up-Regulation Cell Cycle Mutation Promoter Regions, Genetic Polymorphism, Genetic Nomograms Gene Silencing Gene Fusion RNA Interference Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Gene Expression Base Sequence Phosphorylation Diet Polymorphism, Single Nucleotide Drug Synergism Alleles Transcription, Genetic Phenotype Genes, Neoplasm Germ-Line Mutation Algorithms

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Questionnaires Registries SEER Program Radiotherapy, Conformal Base Sequence Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Algorithms

Named Groups4

African Americans European Continental Ancestry Group Survivors African Continental Ancestry Group

Health Care40

Treatment Outcome Watchful Waiting Risk Factors Retrospective Studies Follow-Up Studies Prospective Studies Risk Assessment Survival Rate Survival Analysis Case-Control Studies Risk Sensitivity and Specificity Incidence Disease-Free Survival Cohort Studies Clinical Trials as Topic Odds Ratio Age Factors Kaplan-Meier Estimate Predictive Value of Tests Multivariate Analysis Questionnaires Registries National Cancer Institute (U.S.)SEER Program Nomograms Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Palliative Care Treatment Failure Proportional Hazards Models Patient Selection Feasibility Studies Radiation Injuries Clinical Trials, Phase III as Topic ROC Curve Randomized Controlled Trials as Topic Pilot Projects

Geographicals4

United States Sweden Japan Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Prostatic Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Disease Progression Neoplasm Metastasis Tumor Markers, Biological Adenocarcinoma Mice, Nude Treatment Outcome Prostatic Intraepithelial Neoplasia Antineoplastic Agents Bone Neoplasms Neoplasm Staging Tosyl Compounds Neoplasm Invasiveness Neoplasm Grading Cell Proliferation Prognosis Antineoplastic Agents, Hormonal Watchful Waiting Apoptosis Risk Factors Tumor Cells, Cultured Xenograft Model Antitumor Assays Genetic Predisposition to Disease Neoplasm Proteins Androgen Receptor Antagonists Reverse Transcriptase Polymerase Chain Reaction Breast Neoplasms Retrospective Studies Follow-Up Studies Digital Rectal Examination Anilides Neoplasms RNA, Messenger Neoplasm Transplantation Prospective Studies Transplantation, Heterologous Neoplasm Recurrence, Local Dihydrotestosterone Risk Assessment Finasteride Lung Neoplasms Immunohistochemistry Survival Rate Carcinoma Survival Analysis Blotting, Western United States Drug Resistance, Neoplasm Gene Expression Profiling Combined Modality Therapy Case-Control Studies Risk Signal Transduction Biopsy Transurethral Resection of Prostate Metribolone Prostatic Neoplasms, Castration-Resistant Ovarian Neoplasms Time Factors Taxoids RNA, Small Interfering Cell Growth Processes Sensitivity and Specificity Brachytherapy Cancer Vaccines Down-Regulation Flutamide Cell Survival Genotype Anticarcinogenic Agents Incidence Disease-Free Survival Mice, SCID Biopsy, Needle Antineoplastic Combined Chemotherapy Protocols Cohort Studies Cell Division Colonic Neoplasms Clinical Trials as Topic Glutamate Carboxypeptidase II Tumor Burden Odds Ratio 5-alpha Reductase Inhibitors Stomach Neoplasms Age Factors Cell Movement PTEN Phosphohydrolase DNA, Neoplasm

No FAQ available that match "treatment options for prostate cancer"